Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

One Value-Priced Biotechnology Giant As investors waited anxiously for Amgen #39;s (Nasdaq: AMGN) earnings report, the United Kingdom #39;s high court snuck in with a stinker.
